MD Revolution has launched RevConnect Workflow, an embedded low-code/no-code integration platform that enables healthcare organizations to seamlessly connect any AI model, analytics tool, or application with the RevCare care management platform. Available now for both full-service and software-as-a-service customers, RevConnect Workflow can be implemented either through MD Revolution’s managed services team or accessed directly by customers to build and manage their own integrated workflows.

SAN DIEGO, Jan. 9, 2025 /PRNewswire-PRWeb/ — MD Revolution, a leader in remote patient monitoring and care management, is proud to announce the launch of its groundbreaking new product offering, RevConnect Workflow. Designed to set a new standard in healthcare technology, RevConnect Workflow is a low-code/no-code integration platform that empowers organizations to seamlessly connect any application, API, or automated workflow to the RevCare care management platform. RevConnect Workflow is available now for MD Revolution’s full-service and software-as-a-service customers.

The Most Extensible Care Management Platform

With RevConnect Workflow, the RevCare platform becomes the most extensible care management solution on the market. By leveraging RevConnect APIs and an embedded integration engine, RevConnect Workflow simplifies and accelerates non-EHR integrations, driving dynamic, personalized patient care that evolves in real time.

“RevConnect Workflow enables seamless connections between RevCare and any AI model, third-party CRM, or analytics tool, unlocking new possibilities for delivering timely, patient-centric care.” said Kyle Williams, CEO of MD Revolution. “Adding this capability on top of our RevConnect EHR Integrations, device connections and OpenAPI unlocks endless possibilities for data-driven care.”

AI-Powered Insights for Better Outcomes

One compelling example of RevConnect Workflow in action is its integration with a third-party AI patient recommendation engine. By connecting this AI model to the RevCare platform, the workflow integration tool processes real-time insights to generate actionable clinical and patient tasks and alerts. This real-time data exchange enhances care team decision-making and improves patient outcomes.

“Our strategy is to let customers harness the power of any AI model directly within RevCare to deliver more informed, personalized care at scale.” said Michael Moore, Chief Product Officer. “The ability to integrate AI-driven recommendations without complex coding ensures RevCare addresses the demands of today while laying the groundwork for tomorrow’s innovative care.”

Seamless Integration Across Systems

RevConnect Workflow’s capabilities extend far beyond AI. It enables seamless integration with any third-party system, including CRMs and advanced analytics platforms. By breaking down data silos, healthcare organizations can create a unified ecosystem where every application and system works in harmony to support patient care.

Key Benefits of RevConnect Workflow Include:

Low-Code/No-Code Functionality: Simplifies integration for IT teams, reducing deployment time and complexity.Real-Time Task Automation: Transforms insights into actionable tasks instantly within the RevCare platform.Flexibility: Connects with any application, API, or system, offering unparalleled adaptability.Enhanced Care Delivery: Drives personalized, proactive care through seamless data and workflow integration.

Immediate Availability

RevConnect Workflow is embedded within the RevCare platform, offering two flexible implementation paths. Organizations can either leverage MD Revolution’s managed services team to create and maintain their custom workflows and integrations, or they can access the low-code/no-code tools directly to build and manage their own integrated workflows. This approach ensures all RevCare customers can take advantage of powerful integration capabilities while choosing the support model that best fits their needs and technical capabilities.

For more information about RevConnect Workflow or to schedule a demonstration, please reach out at mdrevolution.com/contact.

About MD Revolution

MD Revolution is transforming patient care through its remote care management platform that seamlessly integrates with an ecosystem of EHRs, data partners, and devices to power comprehensive remote care for large practices, health systems and healthcare organizations. MD Revolution offers RevCare, a software as a service platform, and RevUp, an end-to-end program, including a clinical care team to manage remote care as an extension of the practice. MD Revolution powers programs for Chronic Care Management, Remote Patient Monitoring, Advanced Primary Care Management, Transitional Care Management, Remote Therapeutic Monitoring, Annual Wellness Visits and more.

Media Contact

Jere Halligan, MD Revolution, 1 6199726586, jere@mdrevolution.com, mdrevolution.com

View original content to download multimedia:https://www.prweb.com/releases/md-revolution-unveils-revconnect-workflow-revolutionizing-patient-care-through-seamless-integration-302346720.html

SOURCE MD Revolution

THE HAGUE, the Netherlands, Jan. 9, 2025 /PRNewswire/ — In a breakthrough that combines art, science and music, Dutch inventor Ap Verheggen has discovered a revolutionary method to combat climate change: removing CO2 from the air in minutes instead of decades. In partnership with startup expert Theo Bouts and scientist Dr. Bob Hoogendoorn, Verheggen established Carbon Vanish, a company focused on making this technology widely available.

The project started with a sculpture commissioned by Deltares, an independent knowledge and research institute in Delft. Verheggen created a tree-like installation with olivine to demonstrate its CO2-absorbing properties. Through collaboration with Hoogendoorn, previously a research supervisor at Deltares, they discovered that water with air bubbles over olivine sped up the CO2 absorption process significantly.

“We were surprised by how quickly the process worked,” says Hoogendoorn. Additional experiments showed that vibrations and music further enhanced the reaction. Verheggen’s next artwork used olivine sand in water, where musical tones and vibrations reduced the CO2 concentration in the air to zero within 30 minutes.

“This shows that art and music can contribute to addressing major global challenges,” Verheggen says. “I see many young people losing hope about climate solutions. Through my art, I want to reinvolve them into the discussion. Art is a language everyone understands.”

Carbon Vanish uses olivine and air bubbles to reduce CO2 levels by half within hours. For example, CO2 levels can drop from 411 ppm to 216 ppm (parts per million). The process results in a chalk-like byproduct that can be used in cement production or as agricultural fertiliser.

Read the full story and other news from The Hague on Stories of Purpose: https://storiesofpurpose.thehague.com/impact/carbonvanish-removes-co2-air-olivine-and-music.

About Ap Verheggen
Ap Verheggen is a Dutch artist, living in The Hague, and inventor known for integrating art, science, and technology to address global challenges. His previous artwork, the SunGlacier, an invention to create around 1200 liters of water per day in the desert, has been exposed during World Expo Dubai. Ap is also known because of his sculptures in West Greenland and the documentary about it, IceBerg Riders.

About The Hague & Partners
The Hague & Partners is the official marketing & acquisition organisation for the promotion of The Hague, focused on residents, visitors, conferences, businesses and institutions. https://thehague.com/en 

View original content:https://www.prnewswire.com/news-releases/olivine-music-and-bubbles-a-new-method-to-remove-co2-in-minutes-302346919.html

SOURCE City of The Hague

SAN JOSE, Calif., Jan. 9, 2025 /PRNewswire/ — The rapidly evolving Musculoskeletal (MSK) healthcare landscape demands innovative, cost-effective solutions that empower patients and improve outcomes. Rising to the challenge, Plethy, Inc., a digital health leader, has partnered with Viscogliosi Brothers through its investment office, Viscogliosi Brothers Watermark Holdings (VBW), which is dedicated to investing in MedTech innovation, forming a groundbreaking long-term collaboration. Together, they aim to transform how personalized, data-driven MSK care is delivered, setting a new standard in HealthTech and InsurTech while addressing the critical needs of patients, providers, and payors.

As part of this strategic alignment, John J. Viscogliosi will join the Plethy board, bringing his deep expertise in scaling healthcare companies and driving innovation in the MSK space. His involvement highlights both organizations’ commitment to visionary leadership in digital MSK care.

The partnership unites Plethy’s award-winning, data-driven patient engagement platform with VB’s extensive expertise in scaling MSK solutions to meet the demands of payors and providers alike. Together, they are poised to tackle the critical need for cost-effective, personalized care solutions by leveraging cutting-edge technology and data-driven analytics.

Plethy’s solutions align seamlessly with the growing demands of HealthTech and InsurTech markets. Plethy’s current client base includes self-insured enterprises, insurance carriers, state funds, captives, medical groups, and health systems, reflecting the platform’s adaptability across diverse healthcare and insurance sectors. Plethy’s innovative solutions have transformed patient care by enabling engagement at home and providing predictive analytics to empower clinicians for tailored recovery plans. VB complements this with its proven track record of scaling neuromusculoskeletal companies, improving care quality, and reducing costs through strategic investments and healthcare innovations.

Key Benefits of the Partnership:

Empowered Patients and Quality Outcomes: Patients actively engaged in their recovery journey, leading to measurable outcomes that providers and payors expect.

Data-Driven Insights: Real-time recovery analytics for clinicians to monitor progress and make evidence-based, personalized decisions.

Meeting Evolving Payor Needs: The partnership addresses the need for maximizing clinical outcomes while ensuring cost efficiency, accelerating patients’ return-to-life and work.

“This partnership is a testament to how the MSK healthcare landscape is being reshaped to meet the demands of an evolving industry. By aligning VB’s proven adaptability with Plethy’s innovative platform, we are creating a future where personalized, data-driven care defines excellence. Together, we will lead the transformation of digital MSK solutions, ensuring a profound and sustainable impact across the healthcare ecosystem.” said Anthony G. Viscogliosi, Principal of Viscogliosi Brothers, LLC.

“We are excited to partner with Plethy, a leader in digital health. Together, we’ll set new benchmarks in MSK care, delivering quality and efficiency that the healthcare industry demands.” said John J. Viscogliosi, Chairman of the Board of Directors and & Member of the Investment Committee at Viscogliosi Brothers Watermark Holdings.

“This partnership with VBW reinforces our commitment to transforming digital MSK care. By joining forces, we’ll empower clinicians, enhance patient experiences, and achieve impactful outcomes.” said Raja Sundaram, CEO of Plethy, Inc.

“This partnership leverages advanced analytics and personalized care to deliver better outcomes for patients while addressing healthcare’s cost-efficiency demands.” said Kerem Mavituncalilar, CEO of Viscogliosi Brothers Watermark Holdings.

This collaboration solidifies Plethy and VB as leaders in advancing the MSK healthcare industry. Their combined expertise will drive innovation, improve patient outcomes, and deliver system-wide cost reductions, ensuring that digital MSK solutions become a reality across multiple buying centers and payors.

About Plethy, Inc.: Plethy, Inc. is a leading healthcare technology company at the forefront of patient care and recovery analytics for musculoskeletal disorders, pioneering the use of AI to analyze real-time data for comprehensive, personalized care plans. For more information, visit www.plethy.com.

Viscogliosi Brothers, LLC.  (“VB”) is a New York City-based private equity and venture capital firm specializing in the neuromusculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system. For more information, visit https://www.vbllc.com/  

Viscogliosi Brothers Watermark LLC (“VBW”) is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating alternative wealth for its shareholders while enhancing humanity’s well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing capabilities. For more information, visit https://vbwholdings.com/.

Plethy, Inc.:  Brooke Whitebread, brooke@plethy.com, 747-300-7275

Viscogliosi Brothers, LLC: Ceylan Kendir, ceylank@vbwatermarkholdings.com, +90 (532) 476-4343

View original content to download multimedia:https://www.prnewswire.com/news-releases/plethy-and-vbw-join-forces-to-transform-msk-healthcare-with-data-driven-innovation-302346610.html

SOURCE Plethy, Inc